Abstract
Objective
In this systematic review and meta-analysis, we critically evaluate available evidence regarding the association between primary headaches and subsequent decline of cognitive function and dementia.
Background
Recent studies suggested that headache disorders may increase the risk for dementia. However, available studies are conflicting.
Methods
To identify qualifying studies, we searched scientific databases, including Pubmed, Scopus, Web of Science, Science Direct and BMC, screening for relevant papers. In order to reduce the heterogeneity between different studies, the analyses were further subdivided according to the clinical diagnoses and the study methodologies.
Results
We identified 23 studies investigating the association between primary headaches and the risk of dementia. Of these, 18 met our inclusion criteria for meta-analysis (covering 924.140 individuals). Overall effect-size shows that primary headaches were associated with a small increase in dementia risk (OR = 1,15; CI 95%: 1,03–1,28; p = 0,02). Analyzing subgroups, we found that migraine was associated with both a moderate increased risk of all-cause dementia (OR = 1,26; p = 0,00; 95% CI: 1,13–1,40) as well as a moderate increased risk of Alzheimer’s disease (OR = 2,00; p = 0,00; 95% CI: 1,46–2,75). This association was significant in both case–control and retrospective cohort studies but not in prospective studies.
Conclusions
Our study supports the presence of a link between primary headaches and dementia. However, in the subgroup analysis, only patients with migraine showed a moderate increase risk for all-cause dementia and for Alzheimer’s disease. Additional rigorous studies are needed to elucidate the possible role of primary headaches on the risk of developing cognitive impairment and dementia.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The prevalence of dementia, which encompass a range of progressive and devastating neurodegenerative disorders, continues to increase worldwide, constituting a growing global public health issue [1]. Dementia represents an enormous clinical and economic burden for modern society, being a leading global cause of disability, institutionalization, and mortality [2]. As longevity is constantly increasing, economic and social costs of dementia threaten to overwhelm existing resources [3].
Dementia is a term used to describe an heterogeneous group of neurological disorders characterized by cognitive dysfunction affecting memory, critical thinking and social abilities severe enough to interfere with daily life [4]. Alzheimer’s disease (AD) is the most common cause of dementia. However, different conditions other than AD, like Frontotemporal dementia (FTD), Dementia with Lewy bodies (DLB) and Vascular Dementia (VaD), can cause cognitive impairment. The latter share many cognitive and pathological features with AD [5]. Frequently, patients with a diagnosis of AD present with different mixtures of brain pathologies, complicating both diagnosis, as well as treatment [6]. Therefore, the term Alzheimer’s disease and Related Dementias (ADRD) that encompasses neurodegenerative diseases causing dementia, is often used in epidemiological and pathological studies [7].
ADRD are multifactorial diseases caused by complex interplay of genetic and environmental factors. Recent studies estimate that more than a third of cases are potentially due to modifiable risk factors (e.g. hypertension, physical inactivity, smoking, hypercholesterolemia, overweight and obesity) [8, 9]. Identification of modifiable risk factors for dementia raises opportunity for both primary and secondary prevention plans, explaining the present growing interest in this field [10, 11].
Primary headaches, including migraine, tension-type headache and cluster headache, are one of the most prevalent neurological disorders worldwide [12, 13]. Recently, several epidemiological studies reported a positive association between primary headaches and AD as well as related dementias [14,15,16,17]. This association has been explained on the basis of the comorbidity between primary headaches and cardiovascular diseases, like hypertension and stroke, that are modifiable risk factors for dementia [18, 19]. However, conflicting results emerged in some studies. These findings may be due to differences in diagnostic criteria for cognitive deficits, in methodological strategies, and in the size of investigated populations [20].
The purpose of this study was to perform a systematic review and meta-analysis of the available data regarding association between primary headaches and dementia. In order to reduce previously observed heterogeneity, we investigated separately different primary headaches, and performed further subgroup analysis based on study design (case–control, retrospective and prospective cohort studies).
Methods
Data sources and searches
This study was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) consortium [21]. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) platform (Registration ID: CRD42022380469).
Pubmed, Scopus, Web of Science, Science Direct and BMC were searched for articles investigating headache as possible risk factor for dementia of all causes. Search terms applied for literature search are reported in the Supplementary Material. No language, study design restrictions, or date of publication limit were applied. The search was conducted by one author (A.C.) up to September the 1st, 2022.
Study selection
Only studies in English language, released on peer-reviewed journals involving human subjects with focus on primary headaches as a risk factor for dementia were considered for this systematic review. Reviews, case reports and interventional studies were excluded. Only studies conducted on patients with a diagnosis of primary headache and/or dementia, that investigated possible interactions or relations between the two conditions, were considered. Two blinded and independent investigators (A.C. and L.G.) screened for title and abstracts all the identified studies and excluded papers that did not meet the above-mentioned criteria. Subsequently, the same investigators reviewed the selected articles by full text and excluded papers that did not meet inclusion criteria. The final list of the included articles was then approved by an expert senior reviewer (F.R.).
Data extraction
Investigators (A.G., F.F.) independently extracted data from the articles. The extracted data included: authors, study title, country where the study was conducted, year of publication, study design, sample size, duration of follow-up, age and gender distribution of participants, criteria used for headache and dementia diagnosis and adjusted confounders.
Risk of bias assessment
The Newcastle–Ottawa scale (NOS) was used independently by two investigators (A.G., F.F.) to assess the quality of cohort studies [22]. Points were assigned (stars) for each article considering the following subsections: ranged from 0 to 9 points for cohort studies, participant selection and exposure measurement (0–4 stars), comparability (0–2 stars), outcome assessment and adequacy of follow up (0–3 stars). Higher the number of stars, higher the quality of the study. Scores of 0–3, 4–6, and 7–9 were considered to indicated low, moderate, and high quality, respectively.
Statistical analysis
Statistical analysis was conducted using IBM SPSS Statistics 28.0 software. Distribution frequency of patients with primary headache with or without dementia was extracted for all the included studies. OR with 95% CI was then calculated. Random effect model was used to obtain a pooled measure of ORs (95% CI). Higgins’s I2 statistic was used to evaluate heterogeneity. We considered levels of I2 as follows: 25% low, 25 to 50% moderate, and above 75% high heterogeneity. Publication bias was evaluated through the analysis of asymmetry of the funnel plot and by using the Egger test. Finally, we underwent subgroup analysis stratifying the selected studies based on study design (case control, retrospective or prospective cohort studies), type of headache (primary headaches, migraine) and type of dementia (Alzheimer’s Disease, Vascular Disease). We could not perform other subgroup (e.g. other types of headache, other types of dementia) analysis due to lack of data.
Results
Literature search
The initial search carried out in databases such as Pubmed, Scopus, Web of Science, Science Direct and BMC provided a total of 5926 bibliographical references subdivided as follows: Pubmed 1835, Scopus 6018, Science Direct 344, Web of Science 1352 and BMC 1737. After removing duplicates, 8999 papers were identified. A preliminary screening was carried out through the analysis of title and abstract. After a second screening, a total of 75 articles were selected. By applying inclusion criteria, 23 studies were then identified. Of these, 5 studies were excluded from statistical analysis for the following reasons: two studies did not show data from comparison group; three studies shared the same cohort population of another included article; one study displayed only measures of incidence. Finally, a total of 18 studies were selected for statistical analysis. Selection process pipeline is displayed in Fig. 1.
Characteristics of the included studies and risk of bias analysis
The characteristics of the included studies are summarized in Table 1.
No restriction for study design was applied. Of the 23 [23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45] included papers, 9 were retrospective cohorts, 8 were prospective cohorts and 6 were case–control studies. Only studies which considered all types of primary headaches and dementia were included. As expected for epidemiological reasons, a high percentage of female subjects was found in the patient population. The studies were conducted in the following countries: 4 Korea, 4 Taiwan, 3 UK, 3 USA, 2 Canada, 2 Norway, 1 China, 1 Denmark, 1 Italy, 1 Portugal, 1 Sweden.
In all studies correlation between the two diseases was adjusted on confounders such as age, sex, education, country of origin and/or residence and in many cases also based on the patient’s medical history (comorbidities such as hypertension, diabetes, heart disease or depression).
In the present meta-analysis, thought the analysis of risk of bias, quality was found to be similar when comparing case–control and cohort studies, although case–control studies showed greater in-between score discrepancy. All studies obtained maximum score in the "comparability" section. However, differences in scoring based on study design emerged in the "selection" category: case–control had a score of almost 4 stars while cohort studies had an average of 3 stars. The average score in the “exposure” category was 2.12 points. In this category, half of the articles did not obtain the star for the assessment of exposure; only one did not describe the response rate [25], two articles did not use the same method for cases and controls [24, 42]. Only four studies obtained a star in adequacy of the follow-up category due to the scarcity of information provided by the other included papers [27, 36, 38]. Nonetheless, follow up duration was considered adequate in ten studies (with a single exception) [35]. All studies obtained a star in the “outcome ascertainment” section. One paper obtained a total of five stars [25], so it is considered with a moderate quality, and it is the study in our sample with the lowest score. Two are the studies with a total of 9 stars and therefore with the best rating on the risk of bias [26, 43]. Table 1 of supplementary materials shows the methodological qualities of the studies with NOS criteria.
Association between primary headaches and dementia
We conducted a meta-analysis to investigate the risk of developing dementia (all cause) in people with a history of any type of primary headache. Eighteen articles were included [23, 25,26,27,28,29,30,31, 33, 34, 36,37,38,39,40, 42,43,44,45] in the statistical synthesis. A total of 203.042 patients with primary headaches and a total of 763.249 controls were included in the meta-analysis. The results of the pooling analysis (forest plot Fig. 2) showed that a previous diagnosis of any primary headache was associated with an increased risk of dementia (OR = 1,15; CI 95%: 1,03–1,28; p = 0,02). However, the analysis of I2 index showed high levels of heterogeneity (I2 = 85,9). The analysis of the asymmetry of the funnel plot (Fig. 3) and Egger’s Regression-based Test showed low risk of publication bias (Coefficient = 0,156; SE = 0,0822; t = 1,903; p = 0,075; 95% CI: -0,018–0,331).
To further clarify the high heterogeneity, we conducted a subgroup analysis according to the study design (case control, retrospective cohort, prospective cohort). Statistical analysis showed that both case studies (OR = 1,49; p = 0,00; 95% CI: 1,20–1,85; I2 = 9,2%) and retrospective cohort studies (OR = 1,35; p = 0,00; 95% CI: 1,25–1,45; I2 = 61,9%) were significant and the pooled effect sizes showed a moderate effect of the association between history of headache and risk of dementia, while prospective cohort studies were significant (OR = 0,82; p = 0,00; 95% CI: 0,74–0,92; I2 = 26,9%), but the relation between the two investigated variables was negative. After subgroup analysis, the heterogeneity in each group was considerably low (forest plot Fig. 2). In the other hand, publication bias (Fig. 3) remained low in both case–control and prospective cohort studies (p = 0,101 and p = 0,060), while appeared higher in retrospective cohort studies (p = 0,007).
Association between migraine and dementia
To evaluate also the risk of dementia in migraine we performed a sub-analysis of the studies reporting data about risk of dementia in migraineurs. We included sixteen studies [23, 25,26,27,28,29,30,31, 33, 34, 36, 38, 39, 42,43,44] in the meta-analysis. A total of 107.112 patients with migraine and a total of 346.376 controls were included in the meta-analysis. We calculated pooled effect size (forest plot Fig. 4) and results showed that migraine was associated with a moderate increased of risk of dementia (OR = 1,26; p = 0,00; 95% CI: 1,13–1,40) (Fig. 5). The analysis of I2 index showed high levels of heterogeneity (I2 = 71,5%) and high levels of publication bias (funnel plot Fig. 6; results of Egger’s Regression-based Test: Coefficient = 0,270; SE = 0,0772; t = 3,495; p = 0,004; 95% CI: 0,102–0,438).
Subgroup analysis (forest plot Fig. 4) based on study design showed significant pooled effect size in both case–control (OR = 1,59; p = 0,00; 95% CI: 1,36–1,85) and retrospective cohort studies (OR = 1,37; p = 0,00; 95% CI: 1,13–1,40) and revealed a moderate positive association between migraine and risk of dementia. The analysis of prospective cohort studies showed a negative association between the two variables, but this result was not statistically significant (OR = 0,88; p = 0,16; 95% CI: 0,73–1,05). Heterogeneity was moderate in retrospective cohort groups (I2 = 61,7%) and was low in both case–control and in prospective cohort group (I2 = 0%, I2 = 13,8% respectively). Finally, we found low levels of publication bias (funnel plot Fig. 5) in case-controls and prospective cohort studies (p = 0,219, p = 0,522 respectively) and high levels in retrospective studies (p = 0,020).
Association between Alzheimer’s disease and headache
To evaluate the risk of Alzheimer’s Disease in patients with primary headache we performed a meta-analysis considering only studies reporting data about patients with Alzheimer’s Disease. We included seven studies [27, 28, 31, 33, 38, 44, 45] in the statistical analysis. We calculated pooled effect size (forest plot figure 1 supplementary materials) and results showed that headache was associated with increased of risk of Alzheimer’s disease (OR = 2,07; p = 0,00; 95% CI: 1,57–2,72). The analysis of I2 index showed high levels of heterogeneity (I2 = 85,4%) and high levels of publication bias (results of Egger’s Regression-based Test: Coefficient = 0,563; SE = 0,1900; t = 2,961; p = 0,031; 95% CI: 0,074–1,051) (funnel plot figure 2 supplementary materials).
To also evaluate the risk of Alzheimer’s Disease in migraine patients we performed a sub-analysis of the studies reporting data about risk of Alzheimer’s Disease in migraineurs. We included four studies [28, 31, 33, 38] in the meta-analysis. We calculated pooled effect size (forest plot figure 3 supplementary materials) and results showed that migraine was associated with a moderate increased of risk of Alzheimer’s Disease (OR = 2,00; p = 0,00; 95% CI: 1,46–2,75). The analysis of I2 index showed high levels of heterogeneity (I2 = 87,4%) and low levels of publication bias (results of Egger’s Regression-based Test: Coefficient = 0,284; SE = 0,2029; t = 1,400; p = 0,296; 95% CI: -0,589–1,157) (funnel plot figure 4 supplementary materials).
Association between Vascular Dementia and headache
To evaluate the risk of Vascular Dementia in patients with primary headaches we performed a meta-analysis considering only studies reporting data about patients with Vascular Dementia. We included eight studies [27, 28, 31, 33, 38, 43,44,45] in the statistical analysis. We calculated pooled effect size (forest plot figure 5 supplementary materials) and results showed that headache was associated with increased of risk of Vascular Dementia (OR = 1,31; p = 0,00; 95% CI: 1,18–1,45). The analysis of I2 index showed low levels of heterogeneity (I2 = 0%) and high levels of publication bias (results of Egger’s Regression-based Test: Coefficient = 0,306; SE = 0,0832; t = 3,678; p = 0,010; 95% CI: 0,102–0,510) (funnel plot figure 6 supplementary materials).
To also evaluate the risk of Vascular Dementia in migraine patients we performed a sub-analysis of the studies reporting data about risk of Vascular Dementia in migraineurs. We included six studies [27, 28, 31, 33, 38, 43] in the meta-analysis. We calculated pooled effect size (forest plot figure 7 supplementary materials) and results showed that migraine was associated with a moderate increased of risk of Vascular Dementia (OR = 1,31; p = 0,00; 95% CI: 1,17–1,47). The analysis of I2 index showed low levels of heterogeneity (I2 = 0%) and high levels of publication bias (results of Egger’s Regression-based Test: Coefficient = 0,341; SE = 0,0870; t = 3,916; p = 0,017; 95% CI: 0,099–0,582) (funnel plot figure 8 supplementary materials).
Discussion
In our meta-analysis we found that primary headaches are associated with a small increase in dementia risk. Analyzing subgroups of headache patients, we found that only migraine was associated with a moderate increased risk of both all-cause dementia and Alzheimer’s disease. This association was significant in both case–control and retrospective cohort studies but not in prospective studies. Our data are in accord with four previously published meta-analyses that found a similar increased risk for dementia in patients with a positive history for migraine [14,15,16,17]. However, in comparison with previous studies, we included a large sample of examined individuals and we examined both case–control and cohort studies showing than only case–control and retrospective cohort studies clearly support an association between migraine and dementia.
The association between migraine and dementia is still matter of intensive debate. In a recent paper, Vassallo et al. examined in details all the criticisms related to the studies that investigated such interesting but complex association [46]. First of all, frequently the term “headache” and “migraine” are used incorrectly and secondary headaches are often not ruled out. In our study, we selected patients with an ICHD-3 diagnosis of “primary headache” in order to avoid such misclassification. Then, the temporal distance between the onset of primary headaches and dementia may significantly influence the study of such association. Data collection regarding the frequency as well as the severity of migraine attacks is still a major problem for the study of the association. Finally, they observed that there is no clear biological explanation for the association between migraine and dementia.
Several, different pathogenetic mechanisms may explain the association observed between headache and dementia. First of all, many studies have clearly shown that patients with headaches are at significantly increased risk of developing depression [47] while depression is a well-known risk factor for cognitive impairment and dementia [48], and this association is explained by an overlap of common genetic risk factors [49]. It is of interest to note that subjects carrying mutations in the presenilin-1 gene, a gene responsible of early-onset Alzheimer’s disease, frequently complained of headache even in the pre-symptomatic phase of the disease [50].
Then, both primary headaches and dementia have been associated with several vascular risk factors, such as hypertension, diabetes and dyslipidemia [51, 52]. Altered insulin resistance have been described in both primary headaches [53] and dementia [54] and may represent a common link between these diseases. Of particular interest is the recently developed concept of brain insulin resistance, a condition characterized by altered insulin signaling in the central nervous system. Insulin receptors have been found ubiquitously in the brain and their expression is high in select regions such as the cerebellum, cortex, and hypothalamus. Insulin influences cerebral metabolism, increases turnover of neurotransmitters, such as dopamine, and its signaling is important for mitochondrial functioning. Therefore, altered insulin transport across the blood brain barrier as well as altered insulin receptor expression may explained the increased risk of developing cognitive impairment in patients suffering from primary headaches.
Finally, the presence of neuroinflammation is a common feature of dementia. Reactive microgliosis, release of several proinflammatory cytokines, oxidative damage and mitochondrial dysfunction are associated with the pathogenesis of Alzheimer’s disease and related dementia [55]. Recently, the role of neuroinflammation has been investigated also in patients with migraine. Several cytokines, including tumor necrosis factor alpha, interleukin 1, and adiponectin, have been implicated in the pathogenesis of migraine. In addition, studies in experimental animals have demonstrated that immunological responses are involved in the pathogenesis of migraine [56]. Therefore, repeated headache attacks may activated neuroinflammatory mechanisms predisposing the brain to neurodegeneration.
Our study has certain limitations. While the diagnoses of primary headaches or migraine relates to the well validated criteria of the International Headache Society [57], several different diseases may be characterized by dementia. For example, the diagnosis of Alzheimer’s disease may be performed using only clinical [58] or biological [59] criteria. Therefore, the clear association with a specific dementia subtype still needs additional studies. Furthermore, we did not include covariate analysis in this meta-analysis. However, the number of patients included in the meta-analysis is very high, making the conclusions of this study reliable and supporting the need of additional investigations.
In conclusion, our study further supports the presence of a significant association between primary headaches and the risk for developing dementia in advanced age. This association seems to be of particular relevance between migraine and Alzheimer’s disease. However, relationship between primary headaches and dementia needs further, detailed investigations. Indeed, the fact that most of the included prospective studies do not confirm this association might raise the suspicion of the existence of confounding variables.
Data Availability
All collected data are available upon request to corresponding author.
References
Wu YT et al (2017) The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 13(6):327–339. https://doi.org/10.1038/nrneurol.2017.63
Aranda MP et al (2021) Impact of dementia: Health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc 69(7):1774–1783. https://doi.org/10.1111/jgs.17345
Vaupel JW, Villavicencio F, Bergeron-Boucher MP (2021) Demographic perspectives on the rise of longevity. Proc Natl Acad Sci U S A, 118(9). https://doi.org/10.1073/pnas.2019536118
Gale SA, Acar D, Daffner KR (2018) Dementia. Am J Med 131(10):1161–1169. https://doi.org/10.1016/j.amjmed.2018.01.022
(2021) 2021 Alzheimer's disease facts and figures. Alzheimers Dement, 17(3):327–406. https://doi.org/10.1002/alz.12328
Robinson JL et al (2021) The development and convergence of co-pathologies in Alzheimer’s disease. Brain 144(3):953–962. https://doi.org/10.1093/brain/awaa438
Montine TJ et al (2014) Recommendations of the Alzheimer’s disease-related dementias conference. Neurology 83(9):851–860. https://doi.org/10.1212/wnl.0000000000000733
Nianogo RA et al (2022) Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US. JAMA Neurol 79(6):584–591. https://doi.org/10.1001/jamaneurol.2022.0976
Omura JD et al (2022) Modifiable risk factors for Alzheimer disease and related dementias among adults aged ≥45 years - United States, 2019. MMWR Morb Mortal Wkly Rep 71(20):680–685
Baumgart M et al (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 11(6):718–726. https://doi.org/10.1016/j.jalz.2015.05.016
Killin LO et al (2016) Environmental risk factors for dementia: a systematic review. BMC Geriatr 16(1):175. https://doi.org/10.1186/s12877-016-0342-y
Mier RW, Dhadwal S (2018) Primary headaches. Dent Clin North Am 62(4):611–628. https://doi.org/10.1016/j.cden.2018.06.006
Martin PR (2020) Triggers of primary headaches: issues and pathways forward. Headache 60(10):2495–2507. https://doi.org/10.1111/head.13901
Wang J et al (2018) Headache disorder and the risk of dementia: a systematic review and meta-analysis of cohort studies. J Headache Pain 19(1):95. https://doi.org/10.1186/s10194-018-0925-4
Jiang W et al (2022) Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res 34(6):1237–1246. https://doi.org/10.1007/s40520-021-02065-w
Wang L et al (2022) Meta-analysis of association between migraine and risk of dementia. Acta Neurol Scand 145(1):87–93. https://doi.org/10.1111/ane.13528
Gu L, Wang Y, Shu H (2022) Association between migraine and cognitive impairment. J Headache Pain 23(1):88. https://doi.org/10.1186/s10194-022-01462-4
Mahmoud AN et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498. https://doi.org/10.1136/bmjopen-2017-020498
Magalhães JE, Sampaio Rocha-Filho PA (2018) Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations. Headache 58(8):1277–1286. https://doi.org/10.1111/head.13378
Devianne J et al (2022) Is there a link between headache and cognitive disorders? A systematic review. Rev Neurol (Paris) 178(4):285–290. https://doi.org/10.1016/j.neurol.2021.07.023
Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372:n71. https://doi.org/10.1136/bmj.n71
Wells GA, Shea B, O’Connell D et al (2008) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Chuang CS et al (2013) Migraine and risk of dementia: a nationwide retrospective cohort study. Neuroepidemiology 41(3–4):139–145. https://doi.org/10.1159/000353559
Dewey ME, Davidson IA, Copeland JRM (1988) Risk factors for dementia: Evidence from the liverpool study of continuing health in the community. Int J Geriatr Psychiatry 3(4):245–249. https://doi.org/10.1002/gps.930030403
Echiverri K, Jicha GA, Smith JH (2018) Age-related changes in headache days across the cognitive spectrum. Pain Med 19(7):1478–1484. https://doi.org/10.1093/pm/pnx193
George KM et al (2020) Migraine headache and risk of dementia in the atherosclerosis risk in communities neurocognitive study. Headache 60(5):946–953. https://doi.org/10.1111/head.13794
Hagen K et al (2014) Headache as a risk factor for dementia: a prospective population-based study. Cephalalgia 34(5):327–335. https://doi.org/10.1177/0333102413513181
Hurh K et al (2022) Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study. J Headache Pain 23(1):108. https://doi.org/10.1186/s10194-022-01484-y
Islamoska S et al (2020) Mid- to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J Headache Pain 21(1):98. https://doi.org/10.1186/s10194-020-01166-7
Kim SJ et al (2022) Primary headaches increase the risk of dementias: An 8-year nationwide cohort study. PLoS One 17(8):e0273220. https://doi.org/10.1371/journal.pone.0273220
Kostev K, Bohlken J, Jacob L (2019) Association between migraine headaches and dementia in more than 7,400 patients followed in general practices in the United Kingdom. J Alzheimers Dis 71(1):353–360. https://doi.org/10.3233/jad-190581
Lee SY et al (2019) Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort. Medicine (Baltimore) 98(7):e14467. https://doi.org/10.1097/md.0000000000014467
Lee HJ et al (2021) Mid- and late-life migraine is associated with an increased risk of all-cause dementia and Alzheimer's disease, but Not vascular dementia: A nationwide retrospective cohort study. J Pers Med 11(10). https://doi.org/10.3390/jpm11100990
Liang Y et al (2022) Migraine, cognitive decline, and dementia in older adults: A population-based study. J Alzheimers Dis 88(1):263–271. https://doi.org/10.3233/jad-220013
Lin PC et al (2018) Prevalence of pain-related diagnoses in patients with dementia: a nationwide study. J Pain Res 11:1589–1598. https://doi.org/10.2147/jpr.S172875
Martins IP et al (2020) Cognitive aging in migraine sufferers is associated with more subjective complaints but similar age-related decline: a 5-year longitudinal study. J Headache Pain 21(1):31. https://doi.org/10.1186/s10194-020-01100-x
Morgan K, Lilley JM (1994) Risk factors among incident cases of dementia in a representative british sample. Int J Geriatr Psychiatry 9(1):11–15. https://doi.org/10.1002/gps.930090104
Morton RE, St John PD, Tyas SL (2019) Migraine and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults. Int J Geriatr Psychiatry 34(11):1667–1676. https://doi.org/10.1002/gps.5180
(2013) Abstracts of the 2013 International Headache Congress, 27–30 June 2013, John B. Hynes Veterans Memorial, Convention Center, Boston, MA, USA. Cephalalgia 33(8_suppl):1–309. https://doi.org/10.1177/0333102413490487
Recchia A et al (2016) P4–237: Headaches and dementia in the Oldest-Old: The Monzino 80-plus population-based study. Alzheimer’s Dementia 12(7S_Part_23):P1120–P1121. https://doi.org/10.1016/j.jalz.2016.06.2329
Stræte Røttereng AK et al (2015) Headache as a predictor for dementia: The HUNT Study. J Headache Pain 16:89. https://doi.org/10.1186/s10194-015-0573-x
Tyas SL et al (2001) Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba. Canada Int J Epidemiol 30(3):590–597. https://doi.org/10.1093/ije/30.3.590
Tzeng NS et al (2017) Headaches and risk of dementia. Am J Med Sci 353(3):197–206. https://doi.org/10.1016/j.amjms.2016.12.014
Yang FC et al (2016) Increased Risk of dementia in patients with tension-type headache: A nationwide retrospective population-based cohort Study. PLoS One 11(6):e0156097. https://doi.org/10.1371/journal.pone.0156097
Yin JH et al (2018) Age-specific and gender-dependent impact of primary headache disorders on dementia risk: Population-based longitudinal study. Medicine (Baltimore) 97(52):e13789. https://doi.org/10.1097/md.0000000000013789
Vassallo L et al (2022) The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations. Aging Clin Exp Res 34(8):1947–1948. https://doi.org/10.1007/s40520-022-02169-x
Chen SP, Ayata C (2016) Spreading depression in primary and secondary headache disorders. Curr Pain Headache Rep 20(7):44. https://doi.org/10.1007/s11916-016-0574-8
Botto R et al (2022) Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci 43(7):4107–4124. https://doi.org/10.1007/s10072-022-06068-x
Ye Q, Bai F, Zhang Z (2016) Shared genetic risk factors for late-life depression and Alzheimer’s disease. J Alzheimers Dis 52(1):1–15. https://doi.org/10.3233/jad-151129
Lopera F et al (1997) Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277(10):793–799
Campbell NL et al (2013) Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med 29(4):873–893. https://doi.org/10.1016/j.cger.2013.07.009
Lipnicki DM et al (2019) Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study. PLoS Med 16(7):e1002853. https://doi.org/10.1371/journal.pmed.1002853
Del Moro L et al (2022) Migraine, brain glucose metabolism and the “Neuroenergetic” hypothesis: A scoping review. J Pain 23(8):1294–1317. https://doi.org/10.1016/j.jpain.2022.02.006
Griffith CM et al (2018) Evidence for altered insulin receptor signaling in Alzheimer’s disease. Neuropharmacology 136(Pt B):202–215. https://doi.org/10.1016/j.neuropharm.2018.01.008
Wang X et al (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta 8:1240–1247. https://doi.org/10.1016/j.bbadis.2013.10.015
Ramachandran R et al (2019) Role of Toll-like receptor 4 signaling in mast cell-mediated migraine pain pathway. Mol Pain 15:1744806919867842. https://doi.org/10.1177/1744806919867842
(2018) Headache classification committee of the international headache society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1):1–211. https://doi.org/10.1177/0333102417738202
McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005
Jack CR Jr et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14(4):535–562. https://doi.org/10.1016/j.jalz.2018.02.018
Funding
Open access funding provided by Università degli Studi di Torino within the CRUI-CARE Agreement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent
The study was approved by “Comitato Etico Interaziendale A.O.U. San Giovanni Battista di Torino A.O. C.T.O./Maria Adelaide di Torino”: protocol number 00385/2022.
Conflict of interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cermelli, A., Roveta, F., Giorgis, L. et al. Is headache a risk factor for dementia? A systematic review and meta-analysis. Neurol Sci 45, 1017–1030 (2024). https://doi.org/10.1007/s10072-023-07069-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-07069-0